Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 238431, 9 pages
http://dx.doi.org/10.1155/2015/238431
Review Article

Functional Alteration of Natural Killer Cells and Cytotoxic T Lymphocytes upon Asbestos Exposure and in Malignant Mesothelioma Patients

1Department of Hygiene, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Japan
2Laboratory of Functional Glycobiochemistry, Department of Biofunctional Chemistry, Division of Agricultural and Life Science, Graduate School of Environmental and Life Science, Okayama University, Okayama 700-8530, Japan
3Okayama Rosai Hospital, Okayama 702-8055, Japan
4Department of Respiratory Medicine, Hyogo College of Medicine, Nishimomiya 663-8501, Japan
5Department of Medical Oncology, Faculty of Medicine, Kinki University, Sayama 589-8511, Japan

Received 30 June 2014; Accepted 29 September 2014

Academic Editor: Mohammad Owais

Copyright © 2015 Yasumitsu Nishimura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Miura, Y. Nishimura, H. Katsuyama et al., “Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells,” Apoptosis, vol. 11, no. 10, pp. 1825–1835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Maeda, Y. Nishimura, H. Hayashi et al., “Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2,” The American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 3, pp. 470–479, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Maeda, Y. Nishimura, H. Hayashi et al., “Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients,” The American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 4, pp. 795–803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Maeda, S. Yamamoto, Y. Chen et al., “Resistance to asbestos-induced apoptosis with continuous exposure to crocidolite on a human T cell,” Science of the Total Environment, vol. 429, pp. 174–182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Nishimura, Y. Miura, M. Maeda et al., “Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers,” International Journal of Immunopathology and Pharmacology, vol. 22, no. 3, pp. 579–590, 2009. View at Google Scholar · View at Scopus
  6. Y. Nishimura, M. Maeda, N. Kumagai, H. Hayashi, Y. Miura, and T. Otsuki, “Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos,” International Journal of Immunopathology and Pharmacology, vol. 22, no. 4, pp. 879–888, 2009. View at Google Scholar · View at Scopus
  7. N. Kumagai-Takei, Y. Nishimura, M. Maeda et al., “Effect of asbestos exposure on differentiation of cytotoxic t lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells,” The American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 1, pp. 28–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Nishimura, M. Maeda, N. Kumagai-Takei et al., “Effect of asbestos on anti-tumor immunity and immunological alteration in patients with mesothelioma,” in Malignant Mesothelioma, C. Belli, Ed., pp. 31–48, InTech d.o.o., Rijeka, Croatia, 2012. View at Google Scholar
  9. N. Kumagai-Takei, Y. Nishimura, M. Maeda et al., “Functional properties of CD8+ lymphocytes in patients with pleural plaque and malignant mesothelioma,” Journal of Immunological Research, vol. 2014, Article ID 670140, 10 pages, 2014. View at Publisher · View at Google Scholar
  10. D. H. K. Lee and I. J. Selikoff, “Historical background to the asbestos problem,” Environmental Research, vol. 18, no. 2, pp. 300–314, 1979. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Wagner, C. A. Sleggs, and P. Marchand, “Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province,” British Journal of Industrial Medicine, vol. 17, pp. 260–271, 1960. View at Google Scholar
  12. E. E. Keal, “Asbestosis and abdominal neoplasms,” The Lancet, vol. 276, no. 7162, pp. 1211–1216, 1960. View at Publisher · View at Google Scholar · View at Scopus
  13. T. B. Mallory, B. Castleman, and E. E. Parris, “Case records of the Massachusetts general hospital, case 33441,” The New England Journal of Medicine, vol. 237, pp. 673–676, 1947. View at Publisher · View at Google Scholar
  14. S. R. Gloyne, “The morbid anatomy and histology of asbestosis,” Tubercle, vol. 14, no. 10, pp. 445–451, 1933. View at Publisher · View at Google Scholar
  15. P. Klempere and C. B. Robin, “Primary neoplasm of the pleura: a report of five cases,” Archives of Pathology, vol. 11, pp. 385–412, 1931. View at Google Scholar
  16. H. E. Robertson, “‘Endothelioma’ of the Pleura,” The Journal of Cancer Research, vol. 8, no. 3, pp. 317–375, 1924. View at Google Scholar
  17. T. A. Sporn and V. L. Roggli, “Mesothelioma,” in Pathology of Asbestos-Associated Diseases, V. L. Roggli, T. D. Oury, and T. A. Sporn, Eds., pp. 104–168, Springer, New York, NY, USA, 2004. View at Google Scholar
  18. B. T. Mossman and A. Churg, “Mechanisms in the pathogenesis of asbestosis and silicosis,” The American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, pp. 1666–1680, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. B. T. Mossman, D. W. Kamp, and S. A. Weitzman, “Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers,” Cancer Investigation, vol. 14, no. 5, pp. 466–480, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Dušinská, A. Collins, A. Kažimírová et al., “Genotoxic effects of asbestos in humans,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 553, no. 1-2, pp. 91–102, 2004. View at Publisher · View at Google Scholar
  21. J. Topinka, P. Loli, P. Georgiadis et al., “Mutagenesis by asbestos in the lung of λ-lacI transgenic rats,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 553, no. 1-2, pp. 67–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Bohlig and H. Otto, Asbest und Mesotheliom: Fakten, Fragen, Umweltprobleme, G. Thieme, Stuttgart, Germany, 1975.
  23. R. F. Dodson, J. Huang, and J. R. Bruce, “Asbestos content in the lymph nodes of nonoccupationally exposed individuals,” American Journal of Industrial Medicine, vol. 37, no. 2, pp. 169–174, 2000. View at Google Scholar
  24. R. F. Dodson, M. G. Williams Jr., C. J. Corn, A. Brollo, and C. Bianchi, “A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques,” Annals of the New York Academy of Sciences, vol. 643, pp. 53–60, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Moretta and A. Moretta, “Unravelling natural killer cell function: Triggering and inhibitory human NK receptors,” EMBO Journal, vol. 23, no. 2, pp. 255–259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. W. M. Yokoyama and B. F. M. Plougastel, “Immune functions encoded by the natural killer gene complex,” Nature Reviews Immunology, vol. 3, no. 4, pp. 304–316, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Chen, P. P. Trivedi, B. Ge, K. Krzewski, and J. L. Strominger, “Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 15, pp. 6329–6334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Banchereau and A. K. Palucka, “Dendritic cells as therapeutic vaccines against cancer,” Nature Reviews Immunology, vol. 5, no. 4, pp. 296–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. T. Harty, A. R. Tvinnereim, and D. W. White, “Cd8+ T cell effector mechanisms in resistance to infection,” Annual Review of Immunology, vol. 18, pp. 275–308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Catalfamo and P. A. Henkart, “Perforin and the granule exocytosis cytotoxicity pathway,” Current Opinion in Immunology, vol. 15, no. 5, pp. 522–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. R. S. Allan, J. Waithman, S. Bedoui et al., “Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming,” Immunity, vol. 25, no. 1, pp. 153–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Weninger, N. Manjunath, and U. H. von Andrian, “Migration and differentiation of CD8+ T cells,” Immunological Reviews, vol. 186, pp. 221–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Behrens, M. Li, C. M. Smith et al., “Helper T cells, dendritic cells and CTL Immunity,” Immunology and Cell Biology, vol. 82, no. 1, pp. 84–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Hillerdal and D. W. Henderson, “Asbestos, asbestosis, pleural plaques and lung cancer,” Scandinavian Journal of Work, Environment and Health, vol. 23, no. 2, pp. 93–103, 1997. View at Publisher · View at Google Scholar · View at Scopus